These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 25466768)

  • 1. The effects of North Carolina's prescription drug monitoring program on the prescribing behaviors of the state's providers.
    Ringwalt C; Garrettson M; Alexandridis A
    J Prim Prev; 2015 Apr; 36(2):131-7. PubMed ID: 25466768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of state prescription drug monitoring programs: a state-by-state survey.
    Manasco AT; Griggs C; Leeds R; Langlois BK; Breaud AH; Mitchell PM; Weiner SG
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):847-51. PubMed ID: 27061342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Prescription Drug Monitoring Programs and Prescribing Guidelines on Emergency Department Opioid Prescribing: A Multi-Center Survey.
    Pomerleau AC; Nelson LS; Hoppe JA; Salzman M; Weiss PS; Perrone J
    Pain Med; 2017 May; 18(5):889-897. PubMed ID: 26995800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Controlled Substance Use Management on Prescribing Patterns and Health Outcomes Among High-Risk Users.
    Chen X; Ma Q; Barron J; DeVries A; Horn J; Agiro A
    J Manag Care Spec Pharm; 2019 Mar; 25(3):392-401. PubMed ID: 30816820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of a prescription drug monitoring program to develop algorithms to identify providers with unusual prescribing practices for controlled substances.
    Ringwalt C; Schiro S; Shanahan M; Proescholdbell S; Meder H; Austin A; Sachdeva N
    J Prim Prev; 2015 Oct; 36(5):287-99. PubMed ID: 26143508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Florida's Prescription Drug Monitoring Program registration and utilization: Implications for increasing voluntary use.
    Delcher C; Wang Y; Young HW; Goldberger BA; Schmidt S; Reisfield GM
    J Opioid Manag; 2017; 13(5):283-289. PubMed ID: 29199394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating Emergency Department Opioid Prescribing Behaviors After Education About Mandated Use of the Pennsylvania Prescription Drug Monitoring Program.
    Martello J; Cassidy B; Mitchell A
    J Addict Nurs; 2018; 29(3):196-202. PubMed ID: 30180006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Provider Prescription Drug Monitoring Program Utilization and Self-Auditing-A Pilot Study.
    Brown WC; Whitted K
    J Dr Nurs Pract; 2020 Jul; 13(2):142-147. PubMed ID: 32817503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines.
    Manders L; Abd-Elsayed A
    Pain Physician; 2020 Jun; 23(3):299-304. PubMed ID: 32517396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.
    Rutkow L; Chang HY; Daubresse M; Webster DW; Stuart EA; Alexander GC
    JAMA Intern Med; 2015 Oct; 175(10):1642-9. PubMed ID: 26280092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of New York State Electronic Prescribing Mandate on Opioid Prescribing Patterns.
    Danovich D; Greenstein J; Chacko J; Hahn B; Ardolic B; Ilyaguyev B; Berwald N
    J Emerg Med; 2019 Aug; 57(2):156-161. PubMed ID: 31256931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provider perceptions of system-level opioid prescribing and addiction treatment policies.
    Haffajee RL; French CA
    Curr Opin Psychol; 2019 Dec; 30():65-73. PubMed ID: 30856591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescribing practices, knowledge, and use of prescription drug monitoring programs (PDMP) by a national sample of medical toxicologists, 2012.
    Perrone J; DeRoos FJ; Nelson LS
    J Med Toxicol; 2012 Dec; 8(4):341-52. PubMed ID: 22895794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Provider Compliance With Kentucky's Prescription Drug Monitoring Program's Mandate To Query Patient Opioid History.
    Carey CM; Meille G; Buchmueller TC
    Health Aff (Millwood); 2021 Mar; 40(3):461-468. PubMed ID: 33646863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing.
    Strickler GK; Zhang K; Halpin JF; Bohnert ASB; Baldwin GT; Kreiner PW
    Drug Alcohol Depend; 2019 Jun; 199():1-9. PubMed ID: 30954863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP).
    Lin DH; Lucas E; Murimi IB; Jackson K; Baier M; Frattaroli S; Gielen AC; Moyo P; Simoni-Wastila L; Alexander GC
    Addiction; 2017 Feb; 112(2):311-319. PubMed ID: 27658522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.
    Lin HC; Wang Z; Boyd C; Simoni-Wastila L; Buu A
    Addict Behav; 2018 Jan; 76():348-354. PubMed ID: 28898808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon clinicians.
    Irvine JM; Hallvik SE; Hildebran C; Marino M; Beran T; Deyo RA
    J Pain; 2014 Jul; 15(7):747-55. PubMed ID: 24787089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Opioid Prescribing Habits Based on Analysis of a State Prescription Drug Monitoring Program.
    Alexander JC; Silge J; Jones S; Joshi GP
    Pain Physician; 2019 Sep; 22(5):E425-E433. PubMed ID: 31561654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.